#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Choroid melanoma Retinal dystrophy Bronchiolitis Pelizaeus-Merzbacher disease Hypoparathyroidism Anti-glomerular basement membrane disease General anaesthesia Amyotrophic lateral sclerosis gene carrier Desmoplastic small round cell tumour Optic glioma Ischaemic stroke T-cell lymphoma Synovitis Adrenogenital syndrome Follicular lymphoma More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Diagnostics Propionic acidaemia – Trials in Disease Adrenocortical carcinoma – Basic Information Leukoencephalopathy – Basic Information Familial haemophagocytic lymphohistiocytosis – Life with Disease Testicular leiomyosarcoma – Treatment Glomerulonephritis membranoproliferative – Treatment Osteosarcoma – Trials in Disease Turner’s syndrome Lennox-Gastaut syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rapcabtagene Autoleucel Carcik-Cd19 Cells [14C]ZIPALERTINIB Ganirelix Elritercept Itraconazole Amy109 Carboplatin Donepezil Hydrochloride Ro7790121 Infigratinib CARBOMER 980 Tolvaptan Encorafenib ABY-271 Vimseltinib Ammonium Chloride Hmb-001 Regn7075 Human Immunoglobulin G More therapies…

    Learn about Your Condition

    Poor quality sleep Endometrial stromal sarcoma Procedural hypotension Extraskeletal ossification Pouchitis Anogenital warts Acarodermatitis Penile cancer Astrocytoma malignant Ocular hypertension Craniosynostosis Rhinitis allergic Vertebrobasilar stroke Rhabdomyosarcoma Drug dependence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Chemotherapy with Liposomal Irinotecan, Oxaliplatin, and 5-Fluorouracil for Patients with Pancreatic Cancer Spread to the Liver

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Irinotecan
    • Fluorouracil
    • Folinic Acid
    Germany

  • Study on Heart Amyloidosis Using Sodium Fluoride (18F) and Iodine (123I) Iobenguane for Patients with Transthyretin Amyloid Cardiomyopathy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Iodine (123I) Iobenguane
    • Sodium Fluoride (18F)
    The Netherlands

  • Study on Antibiotic Combination of Ceftriaxone, Clarithromycin, and Metronidazole for Pregnant Women with Threatened Miscarriage and Intact Membranes

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ceftriaxone Sodium
    • Clarithromycin
    • Metronidazole
    France

  • Study on Quality of Life and Brain Function in Patients with Diffuse Low-Grade Gliomas Treated with Temozolomide

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Temozolomide
    France

  • Comparison of Surgical Treatment versus Cabergoline in Patients with Newly Diagnosed Microprolactinomas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prolactin-producing pituitary tumour
    Investigated Drugs:
    • Cabergoline
    Italy

  • Study on the Safety and Tumor-Fighting Effects of OMO-103 for Patients with Advanced Osteosarcoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    Investigated Drugs:
    • Omo-103
    Spain
Previous Page
1 … 856 857 858 859 860 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!